General Principles of Pharmacology and Toxicology

Size: px
Start display at page:

Download "General Principles of Pharmacology and Toxicology"

Transcription

1 General Principles of Pharmacology and Toxicology Parisa Gazerani, Pharm D, PhD Assistant Professor Center for Sensory-Motor Interaction (SMI) Department of Health Science and Technology Aalborg University

2 2 Definitions and units symbols Symbol Units Definition A mg Amount of drug in body AUC mg*hour/l Total area under the plasma drug concentration-time curve AUC 0- mg*hour/l area under the plasma drug concentration-time curve from zero to infinite time AUC iv mg*hour/l area under the plasma drug concentration-time curve after an IV dose AUC oral mg*hour/l area under the plasma drug concentration-time curve after an oral dose C mg/ml Concentration of drug in plasma C 0 mg/ml Concentration of drug in plasma after a single dose extrapolated back to zero time C b mg/ml Concentration of drug in blood CL Total clearance of drug from plasma CL CR Creatinine clearance

3 3 Symbol Units Definition CL GF CL H Renal drug clearance by glumerular filtration Hepatic clearnce of drug from plasma CL int CL R Intrinsic clearance of drug in an organ of elimination Renal clearance of drug CL S Renal drug clearance by tubular secretion C max mg/l Maximum plasma drug concentration during a dosing interval C min mg/l Minimum plasma drug concentration during a dosing interval C ss mg/l Concentration of drug in plasma at steady state during a constant-rate intravenous infusion C uss mg/l Unbound concentration of drug in plasma at steady state during a constant-rate intravenous infusion C u mg/l Unbound drug concentration in plasma

4 4 Symbol Units Definition DR mg/hour Dosing rate E ratio Extraction ratio for an organ E H ratio Hepatic extraction ratio EC 50 mg/l Concentration giving one-half the maximum effect E max varies Maximum effect DR mg/hour Dosing rate E ratio Extraction ratio for an organ E H ratio Hepatic extraction ratio EC 50 mg/l Concentration giving one-half the maximum effect E max varies Maximum effect

5 5 Symbol Units Definition F ratio Bioavailability of drug f e ratio Fraction of drug systematically available that is excreted unchanged in urine f g ratio Fraction of an oral dosethat is absorbed intact into the portal circulation f H ratio Fraction of drug entering the liver that escapes extraction f m ratio Fraction of drug systematically available that is converted to a metabolite FR ratio Fraction of drug reaching the renal tubular fluid that is reabsorbed f u ratio Fraction of drug unbound in plasma f ut ratio Fraction of drug unbound in plasma GFR Glomerular filtration rate k /hour Elimination rate constant

6 6 Symbol Units Definition k a mm Association constant for the binding of drug to protein k m mg/l Michaelis-Menten constant Λ (lambda) ratio Ratio of concentrationof drug in whole blood to that in plasma P u mm Concentration of drug that does not bind drug Q H Hepatic blood flow (portal vein plus hepatic artery) V L Volume of distribution v mg/hour Velocity of enzyme reaction (conversion of drug to metabolite) V max mg/hour Maximal rate of enzyme reaction of saturating substrate concentration V p L Plasma volume V T L Physiologic volume outside plasma into which drug distributes Τ (tau) hour Dosing interval

7 7 Equations Elimination rate: CLxC Elimination rate = clearance (CL)xplasma drug concentration(c) mg/hour mg/l DR = CLxC ss Maintenance dose rate (DR) = clearance (CL)xsteady state drug concentration (C ss ) mg/hour mg/l C b = Cxλ and then λ = C b/ C Plasma concentration ratio = drug concentration in whole blood drug concentration in plasma

8 8 V = A/C Volume of distribution = total amount of drug in the body /plasma drug concentration V = V p + f u /f ut x V T Volume of distribution = plasma volume + fraction unbound in plasma fraction unbound in tissue x tissue volume Loading dose = V x C Loading dose = volume of distribution x target plasma concentration C t = C 0 x e kt Concentration at various time after the dose = Concentration at time zero x e kt K is elimination rate constant and t is time.

9 9 T 1/2 = 0.693/k Half-life (a reciprocal function of elimination rate constant) is the natural logarithm of xV T 1/2 =, K = CL/V CL CL H = Q H xe H Hepatic clearance = hepatic blood flow x hepatic extraction ratio E H = f u xcl int Q H + f u x CL int Unbound fraction x intrinsic clearance Extraction ratio = Blood flow + Unbound fraction x intrinsic clearance

10 10 CL int = V max /K m V max is the maximal velocity of the reaction at saturating substrate concentration or the maximal rate at which the enzyme can convert the drug to a metabolite. Km is the Michaelis constant and expresses how tightly the enzyme binds the drug substrate, the lower the Km, the tighter the binding! C LH = QH x f u xcl int Q H + f u x CL int F = f g x f H Bioavailability = fraction absorbed x fraction escaping first pass clearance F = AUC oral / AUC iv f H= 1 E H (the max oral bioavailability if the drug was totally absorbed from the gut into the portal circulation, fg = 1)

11 11 CL = CL R + CL H Total clearance = renal clearance + hepatic clearance f e = CL R /CL Fraction excreted unchanged = renal clearance/total clearance CL R = f u (GFR + CLs) (1- FR) Rnal clearance is the sum of glomerular filtration clearance (f u xgfr) and secretion clearance (f u x CL s ) multiplied by the fraction of drug that escapes reabsoption from the renal tubule (1- FR). F u = C u /C Fraction unbound = unbound drug concentration/total drug concentration Css = (FxDR)/CL Css is the steady state blood concentration and is a function of the dose rate, the bioavailability and the clearance of the drug.

12 12 CL () = dose (mg) AUC 0- (mgxhour/l) The AUC from zero time to the last plasma sample is determined as a number of trapezoids, and the area from the last data point (C last ) to infinite time is calculated as C last /k, where k is the elimination rate constant of the lowest elimination phase. V (L) = CL = t 1/2 (hour) xcl () F xdose (mg) AUC 0-

General Principles of Pharmacology and Toxicology

General Principles of Pharmacology and Toxicology General Principles of Pharmacology and Toxicology Parisa Gazerani, Pharm D, PhD Assistant Professor Center for Sensory-Motor Interaction (SMI) Department of Health Science and Technology Aalborg University

More information

PHA5128 Dose Optimization II Case Study I Spring 2013

PHA5128 Dose Optimization II Case Study I Spring 2013 Silsamicin is an investigational compound being evaluated for its antimicrobial effect. The route of administration for this drug is via intravenous bolus. Approximately 99.9% of this drug is eliminated

More information

BASIC PHARMACOKINETICS

BASIC PHARMACOKINETICS BASIC PHARMACOKINETICS MOHSEN A. HEDAYA CRC Press Taylor & Francis Croup Boca Raton London New York CRC Press is an imprint of the Taylor & Francis Group, an informa business Table of Contents Chapter

More information

CLINICAL PHARMACOKINETICS INDEPENDENT LEARNING MODULE

CLINICAL PHARMACOKINETICS INDEPENDENT LEARNING MODULE CLINICAL PHARMACOKINETICS INDEPENDENT LEARNING MODULE Joseph K. Ritter, Ph.D. Assoc. Professor, Pharmacology and Toxicology MSB 536, 828-1022, jritter@vcu.edu This self study module will reinforce the

More information

PHA Second Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Second Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 5127 Second Exam Fall 2013 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Question/Points Set I 20 pts Set II 20 pts Set III 20 pts Set IV 20 pts Set

More information

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 5127 Second Exam Fall 2012 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Put all answers on the bubble sheet TOTAL /150 pts 1 Question Set I (True or

More information

Renal Function. 1. Glomerular filtration 2. Active tubular secretion 3. Passive tubular reabsorption 4. Excretion

Renal Function. 1. Glomerular filtration 2. Active tubular secretion 3. Passive tubular reabsorption 4. Excretion 59-291 Section 1, Lecture 5 Drug Excretion -most drugs are excreted in urine either as unchanged or drug metabolites Renal Function 1. Glomerular filtration 2. Active tubular secretion 3. Passive tubular

More information

PHA Final Exam Fall 2006

PHA Final Exam Fall 2006 PHA 5127 Final Exam Fall 2006 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Please transfer the answers onto the bubble sheet. The question number refers

More information

Basic Concepts of TDM

Basic Concepts of TDM TDM Lecture 1 5 th stage What is TDM? Basic Concepts of TDM Therapeutic drug monitoring (TDM) is a branch of clinical pharmacology that specializes in the measurement of medication concentrations in blood.

More information

PHA 5127 FINAL EXAM FALL On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA 5127 FINAL EXAM FALL On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 5127 FINAL EXAM FALL 1997 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Question Points 1. /14 pts 2. /10 pts 3. /8 pts 4 /8 pts 5. /12 pts 6. /8 pts

More information

Renal Clearance. Dr. Eman El Eter

Renal Clearance. Dr. Eman El Eter Renal Clearance Dr. Eman El Eter Concept of clearance Clearance is the volume of plasma that is completely cleared of a substance each minute. Example: Renal clearance of Substance X is defined as the

More information

PHA First Exam Fall 2003

PHA First Exam Fall 2003 PHA 5127 First Exam Fall 2003 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Question/Points 1. /14 pts 2. /6 pts 3. /15 pts 4. /12 pts 5. /20 pts 6. /10pts

More information

PHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 5127 Final Exam Fall 2012 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Please transfer the answers onto the bubble sheet. The question number refers

More information

TDM. Measurement techniques used to determine cyclosporine level include:

TDM. Measurement techniques used to determine cyclosporine level include: TDM Lecture 15: Cyclosporine. Cyclosporine is a cyclic polypeptide medication with immunosuppressant effect. It has the ability to block the production of interleukin-2 and other cytokines by T-lymphocytes.

More information

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 5127 Second Exam Fall 2011 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Put all answers on the bubble sheet TOTAL /200 pts 1 Question Set I (True or

More information

1. If the MTC is 100 ng/ml and the MEC is 0.12 ng/ml, which of the following dosing regimen(s) are in the therapeutic window?

1. If the MTC is 100 ng/ml and the MEC is 0.12 ng/ml, which of the following dosing regimen(s) are in the therapeutic window? Page 1 PHAR 750: Biopharmaceutics/Pharmacokinetics October 23, 2009 - Form 1 Name: Total 100 points Please choose the BEST answer of those provided. For numerical answers, choose none of the above if your

More information

Renal Impairment From Dettli to Guideline: What can we learn?

Renal Impairment From Dettli to Guideline: What can we learn? Renal Impairment From Dettli to Guideline: What can we learn? SocraMetrics GmbH Mainzerhofplatz 14 99084 Erfurt phone: ++49-361-6020526 fax: ++49-361-6020525 e-mail: meinolf.wonnemann@socrametrics.de SocraMetrics

More information

Drug elimination and Hepatic clearance Chapter 6

Drug elimination and Hepatic clearance Chapter 6 Drug elimination and Hepatic clearance Chapter 6 DRUG ELIMINATION Drugs are removed from the body by various elimination processes. Drug elimination refers to the irreversible removal of drug from the

More information

Basic Concepts in Pharmacokinetics. Leon Aarons Manchester Pharmacy School University of Manchester

Basic Concepts in Pharmacokinetics. Leon Aarons Manchester Pharmacy School University of Manchester Basic Concepts in Pharmacokinetics Leon Aarons Manchester Pharmacy School University of Manchester Objectives 1. Define pharmacokinetics 2. Describe absorption 3. Describe distribution 4. Describe elimination

More information

PHA First Exam. Fall 2004

PHA First Exam. Fall 2004 PHA 5127 First Exam Fall 2004 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Put all answers on the bubble sheet. If you need to comment or question a problem

More information

LD = (Vd x Cp)/F (Vd x Cp)/F MD = (Css x CL x T)/F DR = (Css x (Vm-DR))/Km Css = (F x D)/(CL x T) (Km x DR)/(Vm DR)

LD = (Vd x Cp)/F (Vd x Cp)/F MD = (Css x CL x T)/F DR = (Css x (Vm-DR))/Km Css = (F x D)/(CL x T) (Km x DR)/(Vm DR) PHARMKIN WORKSHOP A PHARMACOKINETICS TEACHING SIMULATION Joseph K. Ritter, Ph.D. Associate Professor, Pharmacology and Toxicology MSB 536, 828-1022, jritter@mail2.vcu.edu Tompkins-McCaw Libray Room 2-006

More information

Nonlinear Pharmacokinetics

Nonlinear Pharmacokinetics Nonlinear Pharmacokinetics Non linear pharmacokinetics: In some cases, the kinetics of a pharmacokinetic process change from predominantly first order to predominantly zero order with increasing dose or

More information

Basic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook with Computer Simulations

Basic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook with Computer Simulations Basic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook with Computer Simulations Rosenbaum, Sara E. ISBN-13: 9780470569061 Table of Contents 1 Introduction to Pharmacokinetics and Pharmacodynamics.

More information

BIOL 2402 Renal Function

BIOL 2402 Renal Function BIOL 2402 Renal Function Dr. Chris Doumen Collin County Community College 1 Renal Clearance and GFR Refers to the volume of blood plasma from which a component is completely removed in one minute by all

More information

PHA 5128 Final Exam Spring 2004 Version A. On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA 5128 Final Exam Spring 2004 Version A. On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 5128 Final Exam Spring 2004 Version A On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name There are 18 questions. Total /120 pts Final 2004 1 1. T.P., a 66-year-old,

More information

Rational Dose Prediction. Pharmacology. φαρμακον. What does this mean? pharmakon. Medicine Poison Magic Spell

Rational Dose Prediction. Pharmacology. φαρμακον. What does this mean? pharmakon. Medicine Poison Magic Spell 1 Rational Dose Prediction Nick Holford Dept Pharmacology & Clinical Pharmacology University of Auckland, New Zealand 2 Pharmacology Pharmacology is derived from a Greek word (pharmakon). The Greeks used

More information

TDM. Generally, hepatic clearance is determined by three main factors: These three factors can be employed in the following equation:

TDM. Generally, hepatic clearance is determined by three main factors: These three factors can be employed in the following equation: Lecture 9: Very important supplements TDM Effect of hepatic disease on drugs monitoring: Generally, hepatic clearance is determined by three main factors: - Liver blood flow (LBF). - Intrinsic capacity

More information

PHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 5127 Final Exam Fall 2010 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Please transfer the answers onto the bubble sheet. The question number refers

More information

Biomath M263 Clinical Pharmacology

Biomath M263 Clinical Pharmacology Training Program in Translational Science Biomath M263 Clinical Pharmacology Spring 2013 www.ctsi.ucla.edu/education/training/webcasts Wednesdays 3 PM room 17-187 CHS 4/3/2013 Pharmacokinetics and Pharmacodynamics

More information

Drug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila

Drug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila Drug Dosing in Renal Insufficiency Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila Declaration of Conflict of Interest For today s lecture on Drug Dosing in Renal

More information

Renal Physiology. April, J. Mohan, PhD. Lecturer, Physiology Unit, Faculty of Medical Sciences, U.W.I., St Augustine.

Renal Physiology. April, J. Mohan, PhD. Lecturer, Physiology Unit, Faculty of Medical Sciences, U.W.I., St Augustine. Renal Physiology April, 2011 J. Mohan, PhD. Lecturer, Physiology Unit, Faculty of Medical Sciences, U.W.I., St Augustine. Office : Room 105, Physiology Unit. References: Koeppen B.E. & Stanton B.A. (2010).

More information

You should know the T max for any substance that you use and for PAH ; T max = mg / min

You should know the T max for any substance that you use and for PAH ; T max = mg / min Tubular function - What is clearance? o clearance referred to the theoretical volume of plasma from which a substance is cleared ( cleaned ) over a period of time and so its unit would be ((ml/min)) -

More information

RENAL SYSTEM 2 TRANSPORT PROPERTIES OF NEPHRON SEGMENTS Emma Jakoi, Ph.D.

RENAL SYSTEM 2 TRANSPORT PROPERTIES OF NEPHRON SEGMENTS Emma Jakoi, Ph.D. RENAL SYSTEM 2 TRANSPORT PROPERTIES OF NEPHRON SEGMENTS Emma Jakoi, Ph.D. Learning Objectives 1. Identify the region of the renal tubule in which reabsorption and secretion occur. 2. Describe the cellular

More information

Lippincott Questions Pharmacology

Lippincott Questions Pharmacology Lippincott Questions Pharmacology Edition Two: Chapter One: 1.Which one of the following statements is CORRECT? A. Weak bases are absorbed efficiently across the epithelial cells of the stomach. B. Coadministration

More information

One-Compartment Open Model: Intravenous Bolus Administration:

One-Compartment Open Model: Intravenous Bolus Administration: One-Compartment Open Model: Intravenous Bolus Administration: Introduction The most common and most desirable route of drug administration is orally by mouth using tablets, capsules, or oral solutions.

More information

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 5127 Second Exam Fall 2010 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Put all answers on the bubble sheet TOTAL /200 pts 1 Question Set I (True or

More information

Pharmacokinetics of Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Pharmacokinetics of Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Pharmacokinetics of Drugs Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Absorption Is the transfer of a drug from its site of administration to the bloodstream.

More information

PHA Spring First Exam. 8 Aminoglycosides (5 points)

PHA Spring First Exam. 8 Aminoglycosides (5 points) PHA 5128 Spring 2012 First Exam 1 Aminoglycosides (5 points) 2 Aminoglycosides (10 points) 3 Basic Principles (5 points) 4 Basic Principles (5 points) 5 Bioavailability (5 points) 6 Vancomycin (5 points)

More information

Understand the physiological determinants of extent and rate of absorption

Understand the physiological determinants of extent and rate of absorption Absorption and Half-Life Nick Holford Dept Pharmacology & Clinical Pharmacology University of Auckland, New Zealand Objectives Understand the physiological determinants of extent and rate of absorption

More information

Estimation of Serum Creatinine, Urine Creatinine and Creatinine Clearance. BCH472 [Practical] 1

Estimation of Serum Creatinine, Urine Creatinine and Creatinine Clearance. BCH472 [Practical] 1 Estimation of Serum Creatinine, Urine Creatinine and Creatinine Clearance BCH472 [Practical] 1 -Kidney functions: - The kidneys serve three essential functions: 1. They function as filters, removing metabolic

More information

Chapter-V Drug use in renal and hepatic disorders. BY Prof. C.Ramasamy, Head, Dept of Pharmacy Practice SRM College of Pharmacy, SRM University

Chapter-V Drug use in renal and hepatic disorders. BY Prof. C.Ramasamy, Head, Dept of Pharmacy Practice SRM College of Pharmacy, SRM University Chapter-V Drug use in renal and hepatic disorders. BY Prof. C.Ramasamy, Head, Dept of Pharmacy Practice SRM College of Pharmacy, SRM University Estimating renal function An accurate estimation of renal

More information

Nontraditional PharmD Program PRDO 7700 Pharmacokinetics Review Self-Assessment

Nontraditional PharmD Program PRDO 7700 Pharmacokinetics Review Self-Assessment Nontraditional PharmD Program PRDO 7700 Pharmacokinetics Review Self-Assessment Please consider the following questions. If you do not feel confident about the material being covered, then it is recommended

More information

Mechanisms of Drug Action

Mechanisms of Drug Action 10/31/05 Page 1 20.201 Mechanisms of Drug Action Lecture #18: Pharmacokinetics October 31, 2005 Review Dose-response Protein binding, drug transport(ers) Metabolism NOW: PHARMACOKINETICS Circulatory System

More information

PHAR 7632 Chapter 16

PHAR 7632 Chapter 16 PHAR 7632 Chapter 16 Routes of Excretion Routes of Excretion Student Objectives for this Chapter After completing the material in this chapter each student should:- be able to describe the various routes

More information

DRUG ELIMINATION II BILIARY EXCRETION MAMMARY, SALIVARY AND PULMONARY EXCRETION

DRUG ELIMINATION II BILIARY EXCRETION MAMMARY, SALIVARY AND PULMONARY EXCRETION DRUG ELIMINATION II BILIARY EXCRETION MAMMARY, SALIVARY AND PULMONARY EXCRETION ROUTE OF DRUG ADMINISTRATION AND EXTRAHEPATIC DRUG METABOLISM The decline in plasma concentration after drug administration

More information

Name: UFID: PHA Exam 2. Spring 2013

Name: UFID: PHA Exam 2. Spring 2013 PHA 5128 Exam 2 Spring 2013 1 Carbamazepine (5 points) 2 Theophylline (10 points) 3 Gentamicin (10 points) 4 Drug-drug interaction (5 points) 5 Lidocaine (5 points) 6 Cyclosporine (5 points) 7 Phenobarbital

More information

ADME Review. Dr. Joe Ritter Associate Professor of Pharmacology

ADME Review. Dr. Joe Ritter Associate Professor of Pharmacology ADME Review Dr. Joe Ritter Associate Professor of Pharmacology 828-1022 jkritter@vcu.edu What percent of a weak base (pka = 7.5) and weak acid (pka = 3.5) will be respectively ionized in urine of ph 5.5?

More information

Pharmacokinetics Overview

Pharmacokinetics Overview Pharmacokinetics Overview Disclaimer: This handout and the associated lectures are intended as a very superficial overview of pharmacokinetics. Summary of Important Terms and Concepts - Absorption, peak

More information

TDM Lecture 7 5 th Stage. TDM of Digoxin. Uses: Digoxin is usually used in heart failure associated and atrial fibrillation.

TDM Lecture 7 5 th Stage. TDM of Digoxin. Uses: Digoxin is usually used in heart failure associated and atrial fibrillation. TDM Lecture 7 5 th Stage TDM of Digoxin Digoxin uses and elimination Uses: Digoxin is usually used in heart failure associated and atrial fibrillation. Elimination: About 75% of digoxin clearance occurred

More information

Biopharmaceutics. Tips Worth Tweeting. Contributor: Sandra Earle

Biopharmaceutics. Tips Worth Tweeting. Contributor: Sandra Earle Biopharmaceutics C H A P T E R 2 Contributor: Sandra Earle The physiochemical properties of drugs determine how they will move and interact with the body. By understanding a few principles, predictions

More information

Pharmacogenetics and Pharmacokinetics

Pharmacogenetics and Pharmacokinetics Chapter 2 Pharmacogenetics and Pharmacokinetics Mauro Saivezzo/ShutterStock, Inc. L earning O bjectives Upon completion of this chapter, the student will be able to: 1. Recognize the influence of genetic

More information

PHA 5128 Spring 2009 First Exam (Version B)

PHA 5128 Spring 2009 First Exam (Version B) Name: UFID: PHA 5128 Spring 2009 First Exam (Version B) On my honor, I have neither given nor received unauthorized aid in doing this assignment. Print: Sign: Version B Q1: Phenytoin (10) Q2: procainamide

More information

Multiple IV Bolus Dose Administration

Multiple IV Bolus Dose Administration PHARMACOKINETICS Multiple IV Bolus Dose Administration ١ Multiple IV Bolus Dose Administration Objectives: 1) To understand drug accumulation after repeated dose administration 2) To recognize and use

More information

A novel microdose approach to assess bioavailability, intestinal absorption, gut metabolism, and hepatic clearance of simeprevir in healthy volunteers

A novel microdose approach to assess bioavailability, intestinal absorption, gut metabolism, and hepatic clearance of simeprevir in healthy volunteers A novel microdose approach to assess bioavailability, intestinal absorption, gut metabolism, and hepatic clearance of simeprevir in healthy volunteers Sivi Ouwerkerk-Mahadevan, 1 Jan Snoeys, 1 Alex Simion,

More information

PHA5128 Dose Optimization II Case Study 3 Spring 2013

PHA5128 Dose Optimization II Case Study 3 Spring 2013 Use the vancomycin dosing nomogram table below: A female patient, 57 years of age, 5 6 in height and 100 in weight had an infection requiring vancomycin treatment. Her serum creatinine was 0.8 mg/d. What

More information

BIOPHARMACEUTICS and CLINICAL PHARMACY

BIOPHARMACEUTICS and CLINICAL PHARMACY 11 years papers covered BIOPHARMACEUTICS and CLINICAL PHARMACY IV B.Pharm II Semester, Andhra University Topics: Absorption Distribution Protein binding Metabolism Excretion Bioavailability Drug Interactions

More information

General Principles of Pharmacology and Toxicology

General Principles of Pharmacology and Toxicology General Principles of Pharmacology and Toxicology Parisa Gazerani, Pharm D, PhD Assistant Professor Center for Sensory-Motor Interaction (SMI) Department of Health Science and Technology Aalborg University

More information

Regulation of fluid and electrolytes balance

Regulation of fluid and electrolytes balance Regulation of fluid and electrolytes balance Three Compartment Fluid Compartments Intracellular = Cytoplasmic (inside cells) Extracellular compartment is subdivided into Interstitial = Intercellular +

More information

Introduction to Pharmacokinetics (PK) Anson K. Abraham, Ph.D. Associate Principal Scientist, PPDM- QP2 Merck & Co. Inc., West Point, PA 5- June- 2017

Introduction to Pharmacokinetics (PK) Anson K. Abraham, Ph.D. Associate Principal Scientist, PPDM- QP2 Merck & Co. Inc., West Point, PA 5- June- 2017 Introduction to Pharmacokinetics (PK) Anson K. Abraham, Ph.D. Associate Principal Scientist, PPDM- QP2 Merck & Co. Inc., West Point, PA 5- June- 2017 1 Outline Definition & Relevance of Pharmacokinetics

More information

Clearance and Reabsorption. Use the following data to answer these questions. a. plasma flow rate in the afferent arterioles:

Clearance and Reabsorption. Use the following data to answer these questions. a. plasma flow rate in the afferent arterioles: Bio390 thanks to Dr. J.F. Anderson, Dept Zoology Univ. of Florida, Gainesville Clearance and Reabsorption Use the following data to answer these questions. renal inulin clearance: [inulin] arterial plasma

More information

The kidney. (Pseudo) Practical questions. The kidneys are all about keeping the body s homeostasis. for questions Ella

The kidney. (Pseudo) Practical questions. The kidneys are all about keeping the body s homeostasis. for questions Ella The kidney (Pseudo) Practical questions for questions Ella (striemit@gmail.com) The kidneys are all about keeping the body s homeostasis Ingestion Product of metabolism H 2 O Ca ++ Cl - K + Na + H 2 O

More information

Click to edit Master title style

Click to edit Master title style A Short Course in Pharmacokinetics Chris Town Research Pharmacokinetics Outline Pharmacokinetics - Definition Ideal Pharmacokinetic Parameters of a New Drug How do we optimize PK for new compounds Why

More information

Functional morphology of kidneys Clearance

Functional morphology of kidneys Clearance Functional morphology of kidneys Clearance Assoc. Prof. MUDr. Markéta Bébarová, Ph.D. Department of Physiology Faculty of Medicine, Masaryk University This presentation includes only the most important

More information

Winston Spencer Liauw Cancer Care Centre, St George Hospital, Gray Street, Kogarah NSW 2217, Australia

Winston Spencer Liauw Cancer Care Centre, St George Hospital, Gray Street, Kogarah NSW 2217, Australia LINIAL PARMAOLOGY Winston Spencer Liauw ancer are entre, St George ospital, Gray Street, Kogarah NSW 2217, Australia Keywords: linical pharmacology, pharmacology, pharmacokinetics, pharmacodynamics, therapeutics,

More information

BCH472 [Practical] 1

BCH472 [Practical] 1 BCH472 [Practical] 1 1. They function as filters, removing metabolic products and toxins from the blood and excreting them through the urine. 2. They regulate the body s fluid status, electrolyte balance,

More information

Lecture-2 Review of the previous lecture:

Lecture-2 Review of the previous lecture: Lecture-2 Review of the previous lecture: -Kidney s function is to clean the blood by the removing of the waste plus adding some valuable substances -kidney failure will lead to death for many reasons,

More information

Renal Blood flow; Renal Clearance. Dr Sitelbanat

Renal Blood flow; Renal Clearance. Dr Sitelbanat Renal Blood flow; Renal Clearance Dr Sitelbanat Objectives At the end of this lecture student should be able to describe: Renal blood flow Autoregulation of GFR and RBF Regulation of GFR The Calcuation

More information

Metformin Associated Lactic Acidosis. Jun-Ki Park 9/6/11

Metformin Associated Lactic Acidosis. Jun-Ki Park 9/6/11 Metformin Associated Lactic Acidosis Jun-Ki Park 9/6/11 Probably the most common mechanism by which metformin elevates blood lactate is by inducing catecholamine release in those who regulate or prescribe

More information

Principles of Toxicokinetics/Toxicodynanics

Principles of Toxicokinetics/Toxicodynanics Biochemical and Molecular Toxicology ENVR 442; TOXC 442; BIOC 442 Principles of Toxicokinetics/Toxicodynanics Kim L.R. Brouwer, PharmD, PhD kbrouwer@unc.edu; 919-962-7030 Pharmacokinetics/ Toxicokinetics:

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,900 116,000 120M Open access books available International authors and editors Downloads Our

More information

PHA 5128 CASE STUDY 5 (Digoxin, Cyclosporine, and Methotrexate) Spring 2007

PHA 5128 CASE STUDY 5 (Digoxin, Cyclosporine, and Methotrexate) Spring 2007 PHA 5128 CASE STUDY 5 (Digoxin, Cyclosporine, and Methotrexate) Spring 2007 1. L.J., a 30 year old male, was diagnosed congestive heart failure (CHF). He is 5'9" tall and weights 80 kg. He was given Furosemide

More information

Filtration and Reabsorption Amount Filter/d

Filtration and Reabsorption Amount Filter/d Renal Physiology 2011 Lisa M. Harrison-Bernard, PhD Contact me at lharris@lsuhsc.edu Renal Physiology Lecture 3 Renal Clearance and Glomerular Filtration Filtration and Reabsorption Amount Filter/d Amount

More information

PHA 5128 Spring 2000 Final Exam

PHA 5128 Spring 2000 Final Exam PHA 128 Spring 2000 Final Exam On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name TYPED KEY Questions Points 1. /1 2. /1 3. /1 4. /1. /10 6. /10. /10 8. /10

More information

Based on the information in the official labeling, please answer the following:

Based on the information in the official labeling, please answer the following: Quiz # 1 HuBio 543, Autumn 2007 Consider the official labeling (FDA) of three drug products listed below. They are listed by Trade Name. Generic products typically do not have official labeling available

More information

Excretion of Drugs. Prof. Hanan Hagar Pharmacology Unit Medical College

Excretion of Drugs. Prof. Hanan Hagar Pharmacology Unit Medical College Excretion of Drugs Prof. Hanan Hagar Pharmacology Unit Medical College Excretion of Drugs By the end of this lecture, students should be able to! Identify main and minor routes of excretion including renal

More information

Pharmacokinetic parameters: Halflife

Pharmacokinetic parameters: Halflife Pharmacokinetic parameters: Halflife (t 1/2 ) 1. By definition t 1/2 is the time required for the concentration to fall by one half. For drugs with first order kinetics this is a constant. 2. Half-life

More information

Basic Pharmacokinetic Principles Stephen P. Roush, Pharm.D. Clinical Coordinator, Department of Pharmacy

Basic Pharmacokinetic Principles Stephen P. Roush, Pharm.D. Clinical Coordinator, Department of Pharmacy Basic Pharmacokinetic Principles Stephen P. Roush, Pharm.D. Clinical Coordinator, Department of Pharmacy I. General principles Applied pharmacokinetics - the process of using drug concentrations, pharmaco-kinetic

More information

Glomerular Filtration Rate. Hui Li, PhD, FCACB, DABCC

Glomerular Filtration Rate. Hui Li, PhD, FCACB, DABCC Glomerular Filtration Rate Hui Li, PhD, FCACB, DABCC Glomerular Filtration Rate (GFR): Amount of blood that is filtered per unit time through glomeruli. It is a measure of the function of kidneys. The

More information

Evaluation and Quantitative Prediction of Renal Transporter-Mediated Drug-Drug Interactions. Bo Feng, Ph.D. DDI 2017 June 19-21, 2017

Evaluation and Quantitative Prediction of Renal Transporter-Mediated Drug-Drug Interactions. Bo Feng, Ph.D. DDI 2017 June 19-21, 2017 Evaluation and Quantitative Prediction of Renal Transporter-Mediated Drug-Drug Interactions Bo Feng, Ph.D. DDI 2017 June 19-21, 2017 Outline Background of renal transporters. Clinically observed transporter-mediated

More information

Excretion Chapter 29. The Mammalian Excretory System consists of. The Kidney. The Nephron: the basic unit of the kidney.

Excretion Chapter 29. The Mammalian Excretory System consists of. The Kidney. The Nephron: the basic unit of the kidney. Excretion Chapter 29 The Mammalian Excretory System consists of The Kidney 1. Vertebrate kidneys perform A. Ion balance B. Osmotic balance C. Blood pressure D. ph balance E. Excretion F. Hormone production

More information

Adjusting phenytoin dosage in complex patients: how to win friends and influence patient outcomes

Adjusting phenytoin dosage in complex patients: how to win friends and influence patient outcomes Adjusting phenytoin dosage in complex patients: how to win friends and influence patient outcomes Brian Hardy, PharmD, FCSHP, FCCP Coordinator Education and Clinical Programs Department of Pharmacy Sunnybrook

More information

** Accordingly GFR can be estimated by using one urine sample and do creatinine testing.

** Accordingly GFR can be estimated by using one urine sample and do creatinine testing. This sheet includes the lecture and last year s exam. When a patient goes to a clinic, we order 2 tests: 1) kidney function test: in which we measure UREA and CREATININE levels, and electrolytes (Na+,

More information

Pharmacokinetics in Drug Development. Edward P. Acosta, PharmD Professor & Director Division of Clinical Pharmacology Director, CCC PK/PD Core

Pharmacokinetics in Drug Development. Edward P. Acosta, PharmD Professor & Director Division of Clinical Pharmacology Director, CCC PK/PD Core Pharmacokinetics in Drug Development Edward P. Acosta, PharmD Professor & Director Division of Clinical Pharmacology Director, CCC PK/PD Core Finding new drugs: A crap shoot Clinical Development Phase

More information

Pressure Diuresis 9 Sample Student Essays

Pressure Diuresis 9 Sample Student Essays Pressure Diuresis 9 Sample Student Essays Below please find assembled consecutively in one document the brief analyses submitted by nine students in Mammalian Physiology 08 to the Teach Yourself Pressure

More information

Principal Investigator: Marion, Alan, S, M.D., MDS Pharma Services (US) Inc., 621 Rose Street, PO Box 80837, Lincoln, NE 68502, USA

Principal Investigator: Marion, Alan, S, M.D., MDS Pharma Services (US) Inc., 621 Rose Street, PO Box 80837, Lincoln, NE 68502, USA SYNOPSIS Issue Date: 06 October 2008 Document No.: EDMS-PSDB-8954363:2. Name of Sponsor/Company Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Name of Finished Product Name of Active Ingredient(s)

More information

Prediction of the Effects of Renal Impairment on the Clearance for Organic Cation Drugs that. undergo Renal Secretion: A Simulation-Based Study

Prediction of the Effects of Renal Impairment on the Clearance for Organic Cation Drugs that. undergo Renal Secretion: A Simulation-Based Study DMD Fast Forward. Published on February 28, 2018 as DOI: 10.1124/dmd.117.079558 This article has not been copyedited and formatted. The final version may differ from this version. Prediction of the Effects

More information

NOTE FOR GUIDANCE ON TOXICOKINETICS: THE ASSESSMENT OF SYSTEMIC EXPOSURE IN TOXICITY STUDIES S3A

NOTE FOR GUIDANCE ON TOXICOKINETICS: THE ASSESSMENT OF SYSTEMIC EXPOSURE IN TOXICITY STUDIES S3A INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE NOTE FOR GUIDANCE ON TOXICOKINETICS: THE ASSESSMENT

More information

(KFTs) IACLD CME, Monday, February 20, Mohammad Reza Bakhtiari, DCLS, PhD

(KFTs) IACLD CME, Monday, February 20, Mohammad Reza Bakhtiari, DCLS, PhD Kidney Function Tests (KFTs) IACLD CME, Monday, February 20, 2012 Mohammad Reza Bakhtiari, DCLS, PhD Iranian Research Organization for Science & Technology (IROST) Tehran, Iran Composition and Properties

More information

Chapter 23. Composition and Properties of Urine

Chapter 23. Composition and Properties of Urine Chapter 23 Composition and Properties of Urine Composition and Properties of Urine (1 of 2) urinalysis the examination of the physical and chemical properties of urine appearance - clear, almost colorless

More information

PHA 5128 Case Study 4 (Answers) Total Cp = Unbound Cp/fu.

PHA 5128 Case Study 4 (Answers) Total Cp = Unbound Cp/fu. PHA 58 ase Study 4 (Answers) Spring 4. PT is a patient stabilized on chronic phenytoin therapy. She has just been diagnosed with rheumatoid arthritis and her physician would like to start her on high dose

More information

Pharmacokinetics of strong opioids. Susan Addie Specialist palliative care pharmacist

Pharmacokinetics of strong opioids. Susan Addie Specialist palliative care pharmacist Pharmacokinetics of strong opioids Susan Addie Specialist palliative care pharmacist What is the difference between pharmacokinetics and pharmacodynamics? Definitions Pharmacokinetics = what the body does

More information

Pharmacokinetic Calculations

Pharmacokinetic Calculations Pharmacokinetic Calculations Introduction. Pharmacokinetics involves the relationship between concentration of drug (and its metabolites), measured most often in plasma, drug dosage, and time. A vast majority

More information

Pharmacokinetics of Rifampicin in African Children Evaluation of the new WHO dosing guidelines

Pharmacokinetics of Rifampicin in African Children Evaluation of the new WHO dosing guidelines Pharmacokinetics of Rifampicin in African Children Evaluation of the new WHO dosing guidelines Paolo Denti, Carmen Gonzalez-Martinez, Jana Winckler, Adrie Bekker, Heather Zar, Gerry Davies, Annelies van

More information

Physiology questions review

Physiology questions review Physiology questions review 1- The consumption of O2 by the kidney: a- decrease as blood flow increases b- regulated by erythropoiten c- remains constant as blood flow increase d- direct reflects the level

More information

Section 5.2: Pharmacokinetic properties

Section 5.2: Pharmacokinetic properties Section 5.2: Pharmacokinetic properties SmPC training presentation Note: for full information refer to the European Commission s Guideline on summary of product characteristics (SmPC) SmPC Advisory Group

More information

= (6000 ml air / min * 0.04 ml CO 2 / ml air) / 54 ml CO 2 / dl plasma

= (6000 ml air / min * 0.04 ml CO 2 / ml air) / 54 ml CO 2 / dl plasma Bio390 thanks to Dr. J.F. Anderson, Dept Zoology Univ. of Florida, Gainesville RENAL PROBLEMS Calculate the rate of pulmonary clearance of CO 2 given the following information. Cardiac Output: 4.8 L 6

More information

PHA 4120 Second Exam Key Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA 4120 Second Exam Key Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 4120 Second Exam Key Fall 1997 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Question Points 1. /10 ponts 2. /20 points 3. /10 points 4. /10 points

More information

PROBLEM SET 7.1 FLUID VOLUMES, GLOMERULAR FILTRATION AND CLEARANCE

PROBLEM SET 7.1 FLUID VOLUMES, GLOMERULAR FILTRATION AND CLEARANCE PROBLEM SET 7.1 FLUID VOLUMES, GLOMERULAR FILTRATION AND CLEARANCE ANSWER KEY 1. The time course of decay of plasma [inulin] shown in Fig. 6.1.1 can be simultaneously used to determine the ECF volume and

More information

DMPK. APRIL 27 TH 2017 Jan Neelissen Scientific Adviser Science & Technology

DMPK. APRIL 27 TH 2017 Jan Neelissen Scientific Adviser Science & Technology DMPK APRIL 27 TH 2017 Jan Neelissen Scientific Adviser Science & Technology What I learned is a good DMPK profile have acceptable water solubility for development be completely absorbed, preferably via

More information